ArticleQuantitative imaging in medicine and surgery2026
Unenhanced CT quantitative vascular morphometry for detecting central pulmonary embolism: a multicenter study.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute central pulmonary embolism (ACPE) is a life-threatening condition. Its early detection is critical for patient survival. ACPE presents with nonspecific symptoms such as dyspnea, chest pain, and syncope. Physicians frequently rely on unenhanced chest computed tomography (CT) as the initial imaging modality, where measurable vascular alterations may provide valuable diagnostic information for ACPE. This study aimed to develop a nomogram using unenhanced CT features for the early diagnosis of ACPE. Methods: In total, 374 patients were enrolled in this multicenter study. All the patients underwent unenhanced CT and computed tomography pulmonary angiography (CTPA). Of the patients, 302 from Center A were randomly allocated to a training set (70%, n=212) and a validation set (30%, n=90), while 72 patients from two other centers were allocated to an independent test set for external validation. Vascular parameters, including the main pulmonary artery (mPA), inferior vena cava (IVC), azygos vein (AzV) arch, and superior vena cava (SVC) diameters, main pulmonary artery-to-aorta (mPA:AO) ratio, and longitudinal diameter of the main pulmonary artery (L-mPA) diameter from multiplanar reconstruction (MPR), were measured. Computed tomography attenuation at the origin of the pulmonary artery (CT-OPA) was also assessed. A nomogram was constructed using a stepwise logistic regression model. Results: The L-mPA and IVC diameters were independent risk factors for ACPE diagnosis. The nomogram achieved area under the curve (AUC) values of 0.821 [95% confidence interval (CI): 0.726-0.894] in the validation set and 0.827 (95% CI: 0.720-0.906) in the test set, with high specificity ranging from 89.2% (95% CI: 83.0-93.7%) to 96.0% (95% CI: 86.3-99.5%) but moderate sensitivity ranging from 54.6% (95% CI: 32.2-75.6%) to 55.6% (95% CI: 35.3-74.5%) across the two sets. The calibration curve demonstrated excellent goodness-of-fit, and the decision curve analysis (DCA) revealed a favorable clinical net benefit. Conclusions: The L-mPA and IVC diameters on unenhanced CT were identified as independent risk factors for ACPE. The nomogram integrating these predictors performed well in confirming the diagnosis of ACPE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.